Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust

por Bean, Daniel M., Kraljevic, Zeljko, Searle, Thomas, Bendayan, Rebecca, Kevin, O'Gallagher, Pickles, Andrew, Folarin, Amos, Roguski, Lukasz, Noor, Kawsar, Shek, Anthony, Zakeri, Rosita, Shah, Ajay M., Teo, James T.H., Dobson, Richard J.B.
Publicado en Eur J Heart Fail (2020)